Metropolis Healthcare Ltd.

NSE: METROPOLIS | BSE: 542650 | ISIN: INE112L01020 | Industry: Healthcare Services
| Await Turnaround
1975.1000 -19.90 (-1.00%)
NSE Oct 13, 2025 15:31 PM
Volume: 66,091
 

1975.10
-1.00%
Emkay
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
Metropolis Healthcar.. has an average target of 2114.50 from 4 brokers.
More from Metropolis Healthcare Ltd.
Recommended